{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:33:23Z","timestamp":1774632803019,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.urology.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T23:30:02Z","timestamp":1438212602000},"page":"981-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection"],"prefix":"10.1016","volume":"86","author":[{"given":"Nick W.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clint","family":"Cary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Strine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.W.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bihrle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2015.06.004_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ucl.2007.02.013","article-title":"Adult and pediatric testicular teratoma","volume":"34","author":"Carver","year":"2007","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2015.06.004_bib2","first-page":"1159","article-title":"Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors","volume":"170","author":"Sheinfeld","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.06.004_bib3","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/1097-0142(19950501)75:9<2244::AID-CNCR2820750909>3.0.CO;2-I","article-title":"Adult primary pure teratoma of the testis. The Indiana experience","volume":"75","author":"Leibovitch","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2015.06.004_bib4","first-page":"939","article-title":"Primary pure teratoma of the testis","volume":"155","author":"Simmonds","year":"1996","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.06.004_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2004.07.178","article-title":"Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy","volume":"22","author":"Kondagunta","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2015.06.004_bib6","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/jnci\/djp413","article-title":"Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors","volume":"101","author":"Brydoy","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.urology.2015.06.004_bib7","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1200\/JCO.2005.06.882","article-title":"Blood pressure and body mass index in long-term survivors of testicular cancer","volume":"23","author":"Sagstuen","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2015.06.004_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/107327480200900402","article-title":"Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate","volume":"9","author":"Foster","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.urology.2015.06.004_bib9","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM198712033172303","article-title":"Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer","volume":"317","author":"Williams","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2015.06.004_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1078-1439(02)00212-0","article-title":"Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT)","volume":"21","author":"Donohue","year":"2003","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2015.06.004_bib11","first-page":"677","article-title":"No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis","volume":"131","author":"Pizzocaro","year":"1984","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.06.004_bib12","first-page":"1721","article-title":"Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection","volume":"163","author":"Hermans","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.06.004_bib13","first-page":"1155","article-title":"Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis","volume":"170","author":"Pohar","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.06.004_bib14","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1200\/JCO.2005.07.132","article-title":"Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome","volume":"23","author":"Stephenson","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2015.06.004_bib15","first-page":"944","article-title":"Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?","volume":"177","author":"Beck","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.06.004_bib16","first-page":"143","article-title":"Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor","volume":"174","author":"Beck","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.06.004_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.6004\/jnccn.2009.0047","article-title":"NCCN clinical practice guidelines in oncology: testicular cancer","volume":"7","author":"Motzer","year":"2009","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.urology.2015.06.004_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.acuro.2011.06.017","article-title":"[EAU guidelines on testicular cancer: 2011 update. European Association of Urology]","volume":"36","author":"Albers","year":"2012","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.urology.2015.06.004_bib19","first-page":"1287","article-title":"Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?","volume":"174","author":"Beck","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.06.004_bib20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.urology.2014.05.054","article-title":"Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular cancer","volume":"84","author":"Rice","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urology.2015.06.004_bib21","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1200\/JCO.2006.08.1836","article-title":"Late relapses of germ cell malignancies: incidence, management, and prognosis","volume":"24","author":"Oldenburg","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2015.06.004_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00345-006-0060-8","article-title":"Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancer","volume":"24","author":"Beck","year":"2006","journal-title":"World J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515005865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515005865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T21:48:30Z","timestamp":1567028910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429515005865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0090429515005865"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2015.06.004","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}